Aerovate Therapeutics Inc.
October 31, 2024 - by Joey Ramson
$AVTE is leading the Prism MarketView Public Health index and has crossed above the level where it gapped down to in June earlier in the year. The jump today comes from an announcement of a merger between themselves and Jade Biosciences, a privately held biotechnology company focused on developing best-in-class therapies for autoimmune diseases.
